Ray Comenzo, MD from the Tufts Medical Center, Boston, MA discusses the practical applications of genomics in multiple myeloma (MM)…
Browsing: Acute Lymphoblastic Leukemia
Nelson Leung, MD from the Mayo Clinic, Rochester, MN gives an overview of the common kidney problems in multiple myeloma…
Evangelos Terpos, MD, PhD, University of Athens, Athens, Greece gives an overview of the session on imaging and disease assessment…
In this Best of the Day interview from the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Anne…
In this Best of the Day interview from the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Anne…
In this Best of the Day interview from the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Anne…
This Best of the Day activity serves to provide a brief synopsis of the key points presented on thoracic oncology…
How do I participate in a clinical trial? Patient Power Founder and Host, Andrew Schorr, and head and neck cancer…
From our Ask the Expert series, MPN expert Dr. John Mascarenhas of Mount Sinai School of Medicine, answers Patient Power…
MPN specialist Dr. Mark Heaney discusses his role at Columbia University Medical Center and his approach to patient care. As…
The Oncotype DX® 21-gene Recurrence Score® result stratifies patients with breast cancer into low-, intermediate- and high-risk groups that correspond…
Bruce Johnson, MD, from Dana-Farber Cancer Institute, Boston, MA, explains the challenges associated with developing clinical trials for patients with…
At the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), Bruce Johnson, MD, from Dana-Farber Cancer Institute,…
Bruce Johnson, MD of the Dana-Farber Cancer Institute, Boston, MA has recently been elected as President of the American Society…
The American Society of Clinical Oncology (ASCO) has recently elected Bruce Johnson, MD of the Dana-Farber Cancer Institute, Boston, MA…
Eric Low, Chief Executive at Myeloma UK, discusses how global collaboration is key in multiple myeloma research. According to Eric…
Eric Low, Chief Executive of Myeloma UK, explains the evolving strategies for improving the drug development process for therapies for…
Eric Low, Chief Executive of Myeloma UK, discusses recent advances in the development of new drugs for the treatment of…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Keith Kerr, BSc, MB…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Keith Kerr, BSc, MB…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Suresh Ramalingam, MD, from…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Niki Karachaliou, MD, from…
La Dra Enriqueta Felip explica las principales cuestiones que se han tratado en el 6º Congreso Europeo de Cáncer de…
Professor Joseph Mikhael, MD from Mayo Clinic, Scottsdale, AZ talks to us about the use of social media during medical…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg…
Eric Klein, MD from the Glickman Urology & Kidney Institute, Cleveland, OH discusses biopsy-based genomic testing in men with early-stage…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, David Carbone, MD, PhD,…
David Steensma, MD of the Dana-Faber Cancer Institute, Boston, MA discusses the arrival of a new splicing modulator called H3B-8800…
Sahra Ali, MD from Queen’s Centre Castle Hill Hospital, Hull, UK discusses the need to set up a registry for…
David Steensma, MD of the Dana-Faber Cancer Institute, Boston, MA discusses the recurrent mutation in patients with myelodysplastic syndromes (MDS).…
Sonja Zweegman, MD, PhD from the VU University Medical Center, Amsterdam, Netherlands gives an overview of her talk on risk…
Sahra Ali, MD from Queen’s Centre Castle Hill Hospital, Hull, UK gives an overivew of acute myeloid leukemia (AML) in…
Peter Dreger, MD from Heidelberg University Hospital, Heidelberg, Germany gives an overview of his talk on the current role of…
David Steensma, MD of the Dana-Faber Cancer Institute, Boston, MA gives an overview of his talk on how to treat…
Chng Wee Joo, MB, ChB, PhD, FRCP, FRCPath, FAMS from the National University Cancer Institute, Singapore discusses how next-generation sequencing…
Mark Caulfield, MD from Genomics England and Queen Mary University, London, UK gives an overview of the 100,000 Genomes Project,…
Gail Roboz, MD from Weill Medical College of Cornell University, New York, NY gives an overview of her talk on…
David Steensma, MD of the Dana-Faber Cancer institute, Boston, MA gives an overview of his talk on precision medicine for…
Chng Wee Joo, MB, ChB, PhD, FRCP, FRCPath, FAMS from the National University Cancer Institute, Singapore gives an overview of…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg…
This Expert Perspectives activity features the clinical faculty from a symposium held at the 2016 Annual Meeting of the Oncology…
In this presentation from the “CDK 4/6 Inhibitor Therapy for ER+ Metastatic Breast Cancer – Advancing Nursing Care to Improve…
In this presentation from the “CDK 4/6 Inhibitor Therapy for ER+ Metastatic Breast Cancer – Advancing Nursing Care to Improve…
In this presentation from the “CDK 4/6 Inhibitor Therapy for ER+ Metastatic Breast Cancer – Advancing Nursing Care to Improve…
Mohamad Mohty, MD, PhD, from Saint-Antoine Hospital, Paris, France, and President of the European Society for Blood and Marrow Transplantation…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, John…
Chiara Bonini, MD, from San Raffaele Scientific Institute, Milan, Italy, gives an overview of the ongoing randomised Phase III trial…
Bruno Paiva, PhD, from the University of Navarra, Pamplona, Spain discusses open questions in the assessment of response in multiple…
Bruno Paiva, PhD, from the University of Navarra, Pamplona, Spain discusses the current status of novel treatments in multiple myleoma…